Dentinogenesis imperfecta
Dentinogenesis imperfecta is a genetic disorder affecting the development of dentin, the hard tissue beneath the enamel of a tooth. This condition is characterized by discolored, translucent teeth that are prone to wear and breakage. It is often associated with other genetic conditions, such as osteogenesis imperfecta.
Classification[edit | edit source]
Dentinogenesis imperfecta is classified into three types:
- Type I: Occurs in conjunction with osteogenesis imperfecta. Teeth may appear blue-gray or yellow-brown and are often translucent.
- Type II: Also known as hereditary opalescent dentin, this type occurs without any associated systemic disorder. The teeth have a similar appearance to Type I.
- Type III: Known as the Brandywine type, it is rare and primarily found in a racial isolate in Maryland, USA. Teeth may have multiple pulp exposures and shell-like appearance.
Pathophysiology[edit | edit source]
The condition is caused by mutations in the DSPP gene, which encodes for dentin sialophosphoprotein, a protein crucial for normal dentin formation. These mutations lead to abnormal dentin structure, resulting in the characteristic clinical features of the disorder.
Clinical Features[edit | edit source]
Patients with dentinogenesis imperfecta typically present with:
- Discolored teeth, often described as opalescent
- Increased susceptibility to dental caries
- Rapid wear and attrition of teeth
- Possible pulpal exposure and abscess formation
Diagnosis[edit | edit source]
Diagnosis is primarily clinical, supported by radiographic findings. Radiographs may show:
- Obliteration of the pulp chambers
- Short, constricted roots
- "Shell teeth" appearance in Type III
Treatment[edit | edit source]
Management of dentinogenesis imperfecta focuses on preserving tooth structure and function. Treatment options include:
- Dental crowns to protect teeth from wear
- Endodontic therapy for teeth with pulp exposure
- Orthodontic treatment to address malocclusion
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD